{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:26:36Z","timestamp":1791476796637,"version":"4.3.4"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T00:00:00Z","timestamp":1318809600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1038\/bmt.2011.185","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T07:03:19Z","timestamp":1318834999000},"page":"770-790","source":"Crossref","is-referenced-by-count":282,"title":["Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation"],"prefix":"10.1038","volume":"47","author":[{"name":"on behalf of the EBMT Autoimmune Disease Working Party (ADWP) and Paediatric Diseases Working Party (PDWP)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Snowden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Saccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Allez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hawkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rabusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Farge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,17]]},"reference":[{"key":"BFbmt2011185_CR1","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1073\/pnas.82.8.2483","volume":"82","author":"S Ikehara","year":"1985","unstructured":"Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci USA 1985; 82: 2483\u20132487.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2011185_CR2","first-page":"497","volume":"16","author":"AM Marmont","year":"1995","unstructured":"Marmont AM, Van Bekkum DW . Stem cell transplantation for severe autoimmune diseases: new proposals but still unanswered questions. Bone Marrow Transplant 1995; 16: 497\u2013498.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2249.1995.tb03611.x","volume":"100","author":"DM Karussis","year":"1995","unstructured":"Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S . Immunomodulation of autoimmunity in MRL\/lpr mice with syngeneic bone marrow transplantation (SBMT). Clin Exp Immunol 1995; 100: 111\u2013117.","journal-title":"Clin Exp Immunol"},{"key":"BFbmt2011185_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jnr.490410412","volume":"41","author":"RK Burt","year":"1995","unstructured":"Burt RK, Burns W, Ruvolo P, Fischer A, Shiao C, Guimaraes A et al. Syngeneic bone marrow transplantation eliminates V beta 8.2\u2009T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res 1995; 41: 526\u2013531.","journal-title":"J Neurosci Res"},{"key":"BFbmt2011185_CR5","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1182\/blood.V91.7.2609","volume":"91","author":"RK Burt","year":"1998","unstructured":"Burt RK, Padilla J, Begolka WS, Canto MC, Miller SD . Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 1998; 91: 2609\u20132616.","journal-title":"Blood"},{"key":"BFbmt2011185_CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1023\/A:1006682225181","volume":"20","author":"DW van Bekkum","year":"2000","unstructured":"van Bekkum DW . Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20: 10\u201316.","journal-title":"J Clin Immunol"},{"key":"BFbmt2011185_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.beha.2004.04.003","volume":"17","author":"DW van Bekkum","year":"2004","unstructured":"van Bekkum DW . Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 2004; 17: 201\u2013222.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFbmt2011185_CR8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bmt.1700815","volume":"19","author":"JA Snowden","year":"1997","unstructured":"Snowden JA, Patton WN, O'Donnell JL, Hannah EE, Hart DN . Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1997; 19: 1247\u20131250.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR9","first-page":"337","volume":"86","author":"AM Marmont","year":"2001","unstructured":"Marmont AM . Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems. Haematologica 2001; 86: 337\u2013345.","journal-title":"Haematologica"},{"key":"BFbmt2011185_CR10","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(95)90720-3","volume":"345)","author":"A Marmont","year":"1995","unstructured":"Marmont A, Tyndall A, Gratwohl A, Vischer T . Haematopoietic precursor-cell transplants for autoimmune diseases. Lancet 1995; 345): 978.","journal-title":"Lancet"},{"key":"BFbmt2011185_CR11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1700727","volume":"19","author":"A Tyndall","year":"1997","unstructured":"Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997; 19: 643\u2013645.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR12","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.bbmt.2010.03.012","volume":"16","author":"MC Pasquini","year":"2010","unstructured":"Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT et al. Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. Biol Blood Marrow Transplant 2010; 16: 1076\u20131083.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR13","first-page":"1:S1","volume":"45","author":"R Saccardi","year":"2010","unstructured":"Saccardi R (ed). Haematopoietic stem cell transplantation for severe AD. Bone Marrow Transplant 2010; 45: 1:S1\u20131:25.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR14","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1002\/art.22256","volume":"54","author":"RK Burt","year":"2006","unstructured":"Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750\u20133760.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/0961203310370051","volume":"19","author":"L Sun","year":"2010","unstructured":"Sun L . Stem cell transplantation: progress in Asia. Lupus 2010; 19: 1468\u20131473.","journal-title":"Lupus"},{"key":"BFbmt2011185_CR16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617\u20131624.","journal-title":"JAMA"},{"key":"BFbmt2011185_CR17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bmt.1704892","volume":"35","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869\u2013879.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","volume":"95","author":"D Farge","year":"2010","unstructured":"Farge D, Labopin M, Tyndall A, Fassas A, Mancardi GL, Van Laar J et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010; 95: 284\u2013292.","journal-title":"Haematologica"},{"key":"BFbmt2011185_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1700944","volume":"20","author":"A Fassas","year":"1997","unstructured":"Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631\u2013638.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1023\/A:1006686426090","volume":"20","author":"A Fassas","year":"2000","unstructured":"Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al. Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy. J Clin Immunol 2000; 20: 24\u201330.","journal-title":"J Clin Immunol"},{"key":"BFbmt2011185_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1702180","volume":"25","author":"T Koz\u00e1k","year":"2000","unstructured":"Koz\u00e1k T, Havrdov\u00e1 E, Pit'ha J, Gregora E, Pytlik R, Maaloufova J et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000; 25: 525\u2013531.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2011185_CR22","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1038\/sj.bmt.1704055","volume":"32","author":"RK Burt","year":"2003","unstructured":"Burt RK, Oyama Y, Traynor A, Quigley K, Brush M, Rodriguez J et al. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring? Bone Marrow Transplant 2003; 32 (Suppl 1): S65\u2013S67.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR23","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2002-12-3908","volume":"102","author":"RA Nash","year":"2003","unstructured":"Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood 2003; 102: 2364\u20132372.","journal-title":"Blood"},{"key":"BFbmt2011185_CR24","first-page":"306","volume":"88","author":"E Carreras","year":"2003","unstructured":"Carreras E, Saiz A, Mar\u00edn P, Martinez C, Rovira M, Villamor N et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306\u2013314.","journal-title":"Haematologica"},{"key":"BFbmt2011185_CR25","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood-2004-08-3205","volume":"105","author":"R Saccardi","year":"2005","unstructured":"Saccardi R, Mancardi GL, Solari A, Bosi A, Bruzzi P, Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood 2005; 105: 2601\u20132607.","journal-title":"Blood"},{"key":"BFbmt2011185_CR26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.2005.063883","volume":"77","author":"JPA Samijn","year":"2006","unstructured":"Samijn JPA, te Boekhorst PAW, Mondria T, van Doorn PA, Flach HZ, van der Mech\u00e9 FG et al. Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis. J Neurol Neurosurg Psychiatr 2006; 77: 46\u201350.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BFbmt2011185_CR27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing\u2013remitting multiple sclerosis: a phase I\/II study. Lancet Neurol 2009; 8: 244\u2013253.","journal-title":"Lancet Neurol"},{"key":"BFbmt2011185_CR28","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V100.5.1602.h81702001602_1602_1610","volume":"100","author":"PA McSweeney","year":"2002","unstructured":"McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002; 100: 1602\u20131610.","journal-title":"Blood"},{"key":"BFbmt2011185_CR29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"RA Nash","year":"2007","unstructured":"Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007; 110: 1388\u20131396.","journal-title":"Blood"},{"key":"BFbmt2011185_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bmt.1705782","volume":"40","author":"Y Oyama","year":"2007","unstructured":"Oyama Y, Barr WG, Statkute L, Corbridge T, Gonda EA, Jovanovic B et al. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant 2007; 40: 549\u2013555.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FHJ, Zohar S, Schattenberg AV, Fibbe WE et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis 2008; 67: 98\u2013104.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR32","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/1529-0131(199911)42:11<2286::AID-ANR5>3.0.CO;2-X","volume":"42","author":"JA Snowden","year":"1999","unstructured":"Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM . A phase I\/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999; 42: 2286\u20132292.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR33","first-page":"1653","volume":"29","author":"RJ Verburg","year":"2002","unstructured":"Verburg RJ, Mahabali SD, Stiggelbout AM, Sont JK, van Laar JM . High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists. J Rheumatol 2002; 29: 1653\u20131658.","journal-title":"J Rheumatol"},{"key":"BFbmt2011185_CR34","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002; 46: 2301\u20132309.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)05399-9","volume":"353","author":"N Wulffraat","year":"1999","unstructured":"Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W . Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 1999; 353: 550\u2013553.","journal-title":"Lancet"},{"key":"BFbmt2011185_CR36","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.22656","volume":"56","author":"DMC Brinkman","year":"2007","unstructured":"Brinkman DMC, de Kleer IM, ten Cate R, van Rossum MA, Bekkering WP, Fasth A et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. Arthritis Rheum 2007; 56: 2410\u20132421.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.molimm.2008.12.029","volume":"47","author":"M Abinun","year":"2009","unstructured":"Abinun M, Flood TJ, Cant AJ, Veys P, Gennery AR, Foster HE et al. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000\u20132007). Mol Immunol 2009; 47: 46\u201351.","journal-title":"Mol Immunol"},{"key":"BFbmt2011185_CR38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1053\/j.gastro.2004.11.051","volume":"128","author":"Y Oyama","year":"2005","unstructured":"Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005; 128: 552\u2013563.","journal-title":"Gastroenterology"},{"key":"BFbmt2011185_CR39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.2007.128694","volume":"57","author":"A Cassinotti","year":"2008","unstructured":"Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008; 57: 211\u2013217.","journal-title":"Gut"},{"key":"BFbmt2011185_CR40","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1182\/blood-2010-06-292391","volume":"116","author":"RK Burt","year":"2010","unstructured":"Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 2010; 116: 6123\u20136132.","journal-title":"Blood"},{"key":"BFbmt2011185_CR41","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","volume":"297","author":"JC Voltarelli","year":"2007","unstructured":"Voltarelli JC, Couri CEB, Stracieri ABPL, Oliveira MC, Moraes DA, Pieroni F et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297: 1568\u20131576.","journal-title":"JAMA"},{"key":"BFbmt2011185_CR42","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","volume":"301","author":"CEB Couri","year":"2009","unstructured":"Couri CEB, Oliveira MCB, Stracieri ABPL, Moraes DA, Pieroni F, Barros GM et al. C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2009; 301: 1573\u20131579.","journal-title":"JAMA"},{"key":"BFbmt2011185_CR43","first-page":"75","volume":"15","author":"E Snarski","year":"2010","unstructured":"Snarski E, Milczarczyk A, Franek E, Jedrzejczak W . Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1. Ann Transplant 2010; 15: 75\u201379.","journal-title":"Ann Transplant"},{"key":"BFbmt2011185_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","volume":"44","author":"T Daikeler","year":"2009","unstructured":"Daikeler T, H\u00fcgle T, Farge D, Andolina M, Gualandi F, Baldomero H et al. Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant 2009; 44: 27\u201333.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C et al. Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis 2001; 60: 577\u2013584.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR46","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s00415-002-0800-7","volume":"249","author":"A Fassas","year":"2002","unstructured":"Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088\u20131097.","journal-title":"J Neurol"},{"key":"BFbmt2011185_CR47","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.2003.017798","volume":"63","author":"IM De Kleer","year":"2004","unstructured":"De Kleer IM, Brinkman DMC, Ferster A, Abinun M, Quartier P, van der Net JJ et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318\u20131326.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR48","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ard.2003.011205","volume":"63","author":"D Farge","year":"2004","unstructured":"Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR registry. Ann Rheum Dis 2004; 63: 974\u2013981.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","volume":"13","author":"D Jayne","year":"2004","unstructured":"Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13: 168\u2013176.","journal-title":"Lupus"},{"key":"BFbmt2011185_CR50","first-page":"482","volume":"31","author":"JA Snowden","year":"2004","unstructured":"Snowden JA, Passweg J, Moore JJ, Milliken S, Cannell P, van Laar J et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. J Rheumatol 2004; 31: 482\u2013488.","journal-title":"J Rheumatol"},{"key":"BFbmt2011185_CR51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2141.2004.04978.x","volume":"125","author":"JR Passweg","year":"2004","unstructured":"Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G et al. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004; 125: 749\u2013755.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR52","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","volume":"12","author":"R Saccardi","year":"2006","unstructured":"Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 2006; 12: 814\u2013823.","journal-title":"Mult Scler"},{"key":"BFbmt2011185_CR53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"T Daikeler","year":"2007","unstructured":"Daikeler T, K\u00f6tter I, Bocelli Tyndall C, Apperley J, Attarbaschi A, Guardiola P et al. Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature. Ann Rheum Dis 2007; 66: 202\u2013207.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR54","first-page":"1:S6","volume":"45","author":"M Rabusin","year":"2010","unstructured":"Rabusin M . Haematpoietic stem cell transplantation in severe autoimmune diseases in children. Results and new perspectives. Bone Marrow Transplant 2010; 45: 1:S6\u20131:S7.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"BFbmt2011185_CR55","doi-asserted-by":"crossref","first-page":"ii96","DOI":"10.1136\/ard.2004.028340","volume":"63","author":"A Radbruch","year":"2004","unstructured":"Radbruch A, Thiel A . Cell therapy for autoimmune diseases: does it have a future? Ann Rheum Dis 2004; 63 (Suppl 2): ii96\u2013ii101.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR56","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","volume":"30","author":"W Hinterberger","year":"2002","unstructured":"Hinterberger W, Hinterberger-Fischer M, Marmont A . Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753\u2013759.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.bmt.1703833","volume":"31","author":"AM Marmont","year":"2003","unstructured":"Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A . Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 399\u2013402.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2141.2004.05298.x","volume":"128","author":"RE Hough","year":"2005","unstructured":"Hough RE, Snowden JA, Wulffraat NM . Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Br J Haematol 2005; 128: 432\u2013459.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR59","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bbmt.2005.07.009","volume":"11","author":"LM Griffith","year":"2005","unstructured":"Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW et al. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. Biol Blood Marrow Transplant 2005; 11: 862\u2013870.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR60","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bbmt.2006.04.007","volume":"12","author":"AM Marmont","year":"2006","unstructured":"Marmont AM, Dominietto A, Gualandi F, Piaggio G, van Lint MT, Bacigalupo A . Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs. Biol Blood Marrow Transplant 2006; 12: 987\u2013989.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR61","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20041679","volume":"201","author":"PA Muraro","year":"2005","unstructured":"Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, Cassiani-Ingoni R et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201: 805\u2013816.","journal-title":"J Exp Med"},{"key":"BFbmt2011185_CR62","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","volume":"52","author":"D Farge","year":"2005","unstructured":"Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005; 52: 1555\u20131563.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR63","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2005-07-2800","volume":"107","author":"I de Kleer","year":"2006","unstructured":"de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, Yung GP et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107: 1696\u20131702.","journal-title":"Blood"},{"key":"BFbmt2011185_CR64","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2007-12-128488","volume":"111","author":"STA Roord","year":"2008","unstructured":"Roord STA, de Jager W, Boon L, Wulffraat N, Martens A, Prakken B et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells. Blood 2008; 111: 5233\u20135241.","journal-title":"Blood"},{"key":"BFbmt2011185_CR65","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/08916930802200182","volume":"41","author":"F van Wijk","year":"2008","unstructured":"van Wijk F, Roord ST, Vastert B, de Kleer I, Wulffraat N, Prakken BJ . Regulatory T cells in autologous stem cell transplantation for autoimmune disease. Autoimmunity 2008; 41: 585\u2013591.","journal-title":"Autoimmunity"},{"key":"BFbmt2011185_CR66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2008-07-168286","volume":"113","author":"T Alexander","year":"2009","unstructured":"Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, Kohler S et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 2009; 113: 214\u2013223.","journal-title":"Blood"},{"key":"BFbmt2011185_CR67","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.0901773","volume":"183","author":"L Zhang","year":"2009","unstructured":"Zhang L, Bertucci AM, Ramsey-Goldman R, Burt RK, Datta SK . Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J Immunol 2009; 183: 6346\u20136358.","journal-title":"J Immunol"},{"key":"BFbmt2011185_CR68","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.10093","volume":"46","author":"S Bingham","year":"2002","unstructured":"Bingham S, Veale D, Fearon U, Isaacs JD, Morgan G, Emery P et al. High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum 2002; 46: 837\u2013839.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR69","first-page":"1:S2","volume":"45","author":"P Muraro","year":"2010","unstructured":"Muraro P . Restoring self-tolerance: lessons from the clinic. Bone Marrow Transplant 2010; 45: 1:S2.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/kel451","volume":"46","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P et al. Skin involvement in scleroderma\u2014where histological and clinical scores meet. Rheumatology (Oxford) 2007; 46: 833\u2013841.","journal-title":"Rheumatology (Oxford)"},{"key":"BFbmt2011185_CR71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/08916930802197305","volume":"41","author":"D Farge","year":"2008","unstructured":"Farge D, Nash R, Laar JM . Autologous stem cell transplantation for systemic sclerosis. Autoimmunity 2008; 41: 616\u2013624.","journal-title":"Autoimmunity"},{"key":"BFbmt2011185_CR72","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","volume":"3","author":"JN Fleming","year":"2008","unstructured":"Fleming JN, Nash RA, McLeod DO, Fiorentino DF, Shulman HM, Connolly MK et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One 2008; 3: e1452.","journal-title":"PLoS One"},{"key":"BFbmt2011185_CR73","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.2007.082495","volume":"68","author":"I Miniati","year":"2009","unstructured":"Miniati I, Guiducci S, Conforti ML, Rogai V, Fiori G, Cinelli M et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009; 68: 94\u201398.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR74","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3899\/jrheum.081212","volume":"36","author":"D Launay","year":"2009","unstructured":"Launay D, Marjanovic Z, de Bazelaire C, Florea L, Zohar S, Keshtmand H et al. Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring. J Rheumatol 2009; 36: 1460\u20131463.","journal-title":"J Rheumatol"},{"key":"BFbmt2011185_CR75","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","volume":"109","author":"Y Loh","year":"2007","unstructured":"Loh Y, Oyama Y, Statkute L, Quigley K, Yaung K, Gonda E et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood 2007; 109: 2643\u20132548.","journal-title":"Blood"},{"key":"BFbmt2011185_CR76","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1182\/blood-2011-02-336156","volume":"118","author":"T Daikeler","year":"2011","unstructured":"Daikeler T, Labopin M, Di Gioia M, Abinun M, Alexander T, Miniati I et al. Secondary autoimmune diseases occuring after stem cell transplantation for an autoimmune disease: a retrospective study of the European Group for Blood & Marrow Transplantation Autoimmune Diseases Working Party. Blood 2011; 118: 1693\u20131698.","journal-title":"Blood"},{"key":"#cr-split#-BFbmt2011185_CR77.1","doi-asserted-by":"crossref","unstructured":"1. Tailor IK, Akil M, Rennie I, Ross RJ, Snowden JA . Reconstitution Graves' disease following autologous haematopoietic stem cell transplantation (HSCT) for severe diffuse systemic sclerosis. Q J Med 2011","DOI":"10.1093\/qjmed\/hcr050"},{"key":"#cr-split#-BFbmt2011185_CR77.2","unstructured":"2. (e-pub ahead of print 30 March 2011)."},{"key":"BFbmt2011185_CR78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/bmt.2009.141","volume":"45","author":"P Ljungman","year":"2010","unstructured":"Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219\u2013234.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR79","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2010.30.4121","volume":"29","author":"A Gratwohl","year":"2011","unstructured":"Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J et al. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol 2011; 29: 1980\u20131986.","journal-title":"J Clin Oncol"},{"key":"BFbmt2011185_CR80","unstructured":"Chabannon C, Pamphilon D, Vermylen C, Gratwohl A, Niederwieser D, McGrath E et al. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program. Bone Marrow Transplant 2011 (e-pub ahead of print 7 March 2011). Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21383685 (Consult\u00e9 avril 20, 2011)."},{"key":"BFbmt2011185_CR81","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2141.2004.05076.x","volume":"126","author":"U Popat","year":"2004","unstructured":"Popat U, Krance R . Haematopoietic stem cell transplantation for autoimmune disorders: the American perspective. Br J Haematol 2004; 126: 637\u2013649.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR82","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1002\/art.22257","volume":"54","author":"GG Illei","year":"2006","unstructured":"Illei GG . Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty? Arthritis Rheum 2006; 54: 3730\u20133734.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/10245330701255106","volume":"12","author":"S Kapoor","year":"2007","unstructured":"Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L et al. Haemopoietic stem cell transplantation\u2014an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 2007; 12: 179\u2013191.","journal-title":"Hematology"},{"issue":"Suppl 2","key":"BFbmt2011185_CR84","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/bmt.2008.64","volume":"41","author":"M Rabusin","year":"2008","unstructured":"Rabusin M, Andolina M, Maximova N . Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives. Bone Marrow Transplant 2008; 41 (Suppl 2): S96\u2013S99.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/bmt.2009.147","volume":"44","author":"AC Krauss","year":"2009","unstructured":"Krauss AC, Kamani NR . Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. Bone Marrow Transplant 2009; 44: 137\u2013143.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR86","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","volume":"299","author":"RK Burt","year":"2008","unstructured":"Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925\u2013936.","journal-title":"JAMA"},{"issue":"Suppl","key":"BFbmt2011185_CR87","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.bbmt.2009.10.034","volume":"16","author":"KM Sullivan","year":"2010","unstructured":"Sullivan KM, Muraro P, Tyndall A . Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. Biol Blood Marrow Transplant 2010; 16 (Suppl): S48\u2013S56.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR88","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444\u20131452.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/096120300672904669","volume":"9","author":"DA Isenberg","year":"2000","unstructured":"Isenberg DA, Gordon C . From BILAG to BLIPS\u2014disease activity assessment in lupus past, present and future. Lupus 2000; 9: 651\u2013654.","journal-title":"Lupus"},{"key":"BFbmt2011185_CR90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH . Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630\u2013640.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR91","first-page":"719","volume":"28","author":"RJ Verburg","year":"2001","unstructured":"Verburg RJ, Sont JK, Vliet Vlieland TP, Landew\u00e9 RB, Boers M, Kievit J et al. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis. J Rheumatol 2001; 28: 719\u2013727.","journal-title":"J Rheumatol"},{"key":"BFbmt2011185_CR92","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/bmt.2009.305","volume":"45","author":"P Tappenden","year":"2010","unstructured":"Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL et al. Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. Bone Marrow Transplant 2010; 45: 1014\u20131021.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR93","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/bmt.2010.168","volume":"45","author":"H Atkins","year":"2010","unstructured":"Atkins H . Hematopoietic SCT for the treatment of multiple sclerosis. Bone Marrow Transplant 2010; 45: 1671\u20131681.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR94","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/sj.bmt.1701486","volume":"22","author":"JA Snowden","year":"1998","unstructured":"Snowden JA, Biggs JC, Milliken ST, Fuller A, Staniforth D, Passuello F et al. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant 1998; 22: 1035\u20131041.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR95","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1212\/WNL.54.11.2147","volume":"54","author":"H Openshaw","year":"2000","unstructured":"Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP et al. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000; 54: 2147\u20132150.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","volume":"28","author":"RK Burt","year":"2001","unstructured":"Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1\u201312.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR97","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bmt.1705579","volume":"39","author":"L Statkute","year":"2007","unstructured":"Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T et al. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 317\u2013329.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR98","first-page":"108","volume":"22","author":"W Zhang","year":"2007","unstructured":"Zhang W, Zhou D-B, Zhao Y, Zhuang JL, Leng XM, Wang SJ et al. Peripheral blood CD34+ cell mobilization in 42 patients with severe autoimmune disease. Chin Med Sci J 2007; 22: 108\u2013112.","journal-title":"Chin Med Sci J"},{"key":"BFbmt2011185_CR99","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bmt.1704656","volume":"34","author":"R Saccardi","year":"2004","unstructured":"Saccardi R, Tyndall A, Coghlan G, Denton C, Edan G, Emdin M et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004; 34: 877\u2013881.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08916930802200224","volume":"41","author":"NM Wulffraat","year":"2008","unstructured":"Wulffraat NM, van Rooijen EM, Tewarie R, Brinkman D, Prakken B, Kuis W . Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis. Autoimmunity 2008; 41: 632\u2013638.","journal-title":"Autoimmunity"},{"key":"BFbmt2011185_CR101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.bmt.1700924","volume":"20","author":"R Martino","year":"1997","unstructured":"Martino R, Sureda A, Brunet S . Peripheral blood stem cell mobilization in refractory autoimmune Evans syndrome: a cautionary case report. Bone Marrow Transplant 1997; 20: 521.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1704134","volume":"32","author":"W Kreisel","year":"2003","unstructured":"Kreisel W, Potthoff K, Bertz H, Schmitt-Graeff A, Ruf G, Rasenack J et al. Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 2003; 32: 337\u2013340.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"BFbmt2011185_CR103","first-page":"S377","volume":"46","author":"M Rovira","year":"2011","unstructured":"Rovira M, Ricart E, Feu F, Pino S, Comas D, Fernandez-Aviles F et al. Infectious complications during the mobilization phase in patients with refractory Crohn's disease suitable for autologous stem cell transplantation. Bone Marrow Transplant 2011; 46 (Suppl 1): S377\u2013S378.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR104","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/rheumatology\/36.3.390","volume":"36","author":"A Tyndall","year":"1997","unstructured":"Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Br J Rheumatol 1997; 36: 390\u2013392.","journal-title":"Br J Rheumatol"},{"key":"BFbmt2011185_CR105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004310050006","volume":"159","author":"B Bakker","year":"2000","unstructured":"Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM . Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000; 159: 31\u201337.","journal-title":"Eur J Pediatr"},{"key":"BFbmt2011185_CR106","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood-2003-03-0877","volume":"102","author":"RK Burt","year":"2003","unstructured":"Burt RK, Cohen BA, Russell E, Spero K, Joshi A, Oyama Y et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102: 2373\u20132378.","journal-title":"Blood"},{"key":"BFbmt2011185_CR107","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1704671","volume":"34","author":"RK Burt","year":"2004","unstructured":"Burt RK, Patel D, Thomas J, Yeager A, Traynor A, Heipe F et al. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis. Bone Marrow Transplant 2004; 34: 745\u2013751.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bmt.1705710","volume":"40","author":"C Ferry","year":"2007","unstructured":"Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007; 40: 219\u2013224.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11764-007-0006-1","volume":"1","author":"C Eiser","year":"2007","unstructured":"Eiser C, Absolom K, Greenfield D, Snowden J, Coleman R, Hancock B et al. Follow-up care for young adult survivors of cancer: lessons from pediatrics. J Cancer Surviv 2007; 1: 75\u201386.","journal-title":"J Cancer Surviv"},{"key":"BFbmt2011185_CR110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.328.5980.825-e","volume":"328","author":"RK Burt","year":"2010","unstructured":"Burt RK, Abinun M, Farge-Bancel D, Fassas A, Hiepe F, Havrdov\u00e1 E et al. Risks of immune system treatments. Science 2010; 328: 825\u2013826.","journal-title":"Science"},{"key":"BFbmt2011185_CR111","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bmt.1705854","volume":"40","author":"ES Morris","year":"2007","unstructured":"Morris ES, Sharrack B, Dalley CD, Snowden JA . The Uhthoff phenomenon: a potential post transplant complication in advanced progressive multiple sclerosis. Bone Marrow Transplant 2007; 40: 1003\u20131004.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR112","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1083-8791(03)00228-3","volume":"9","author":"RA Nash","year":"2003","unstructured":"Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA et al. Epstein\u2013Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 2003; 9: 583\u2013591.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR113","first-page":"159","volume":"20","author":"XM Leng","year":"2005","unstructured":"Leng XM, Zhao Y, Zhou DB, Situ H, Li TS, Shen T et al. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation. Chin Med Sci J 2005; 20: 159\u2013165.","journal-title":"Chin Med Sci J"},{"key":"BFbmt2011185_CR114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1703324","volume":"29","author":"Y Oyama","year":"2002","unstructured":"Oyama Y, Cohen B, Traynor A, Brush M, Rodriguez J, Burt RK . Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002; 29: 81\u201385.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR115","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/bmt.2009.363","volume":"45","author":"E Carreras","year":"2010","unstructured":"Carreras E, Fern\u00e1ndez-Avil\u00e9s F, Silva L, Guerrero M, Fern\u00e1ndez de Larrea C, Mart\u00ednez C et al. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant 2010; 45: 1417\u20131422.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR116","first-page":"1122","volume":"26","author":"AJ Tyndall","year":"2008","unstructured":"Tyndall AJ, Joly F, Carbonne B, Deligny CN, Farge DC . Pregnancy and childbirth after treatment with autologous hematopoietic stem cell transplantation for severe systemic sclerosis requiring parenteral nutrition. Ethical issues. Clin Exp Rheumatol 2008; 26: 1122\u20131124.","journal-title":"Clin Exp Rheumatol"},{"key":"BFbmt2011185_CR117","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A . Multiple sclerosis. Lancet 2008; 372: 1502\u20131517.","journal-title":"Lancet"},{"key":"BFbmt2011185_CR118","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP et al. Copolymer 1 reduces relapse rate and improves disability in relapsing\u2013remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology 1995; 45: 1268\u20131276.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR119","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","volume":"43","author":"DW Paty","year":"1993","unstructured":"Paty DW, Li DK . Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 1993; 43: 662\u2013667.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"JA Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010; 362: 402\u2013415.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/jnnp.62.2.112","volume":"62","author":"G Edan","year":"1997","unstructured":"Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C et al. Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatr 1997; 62: 112\u2013118.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BFbmt2011185_CR122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003; 348: 15\u201323.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR123","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.0b013e3181dc1ae0","volume":"74","author":"JJ Marriott","year":"2010","unstructured":"Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW . Evidence Report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010; 74: 1463\u20131470.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR124","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1212\/WNL.62.2.282","volume":"62","author":"A Saiz","year":"2004","unstructured":"Saiz A, Blanco Y, Carreras E, Berenguer J, Rovira M, Pujol T et al. Clinical and MRI outcome after autologous hematopoietic stem cell transplantation in MS. Neurology 2004; 62: 282\u2013284.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/1352458505ms1181cr","volume":"11","author":"GL Mancardi","year":"2005","unstructured":"Mancardi GL, Murialdo A, Rossi P, Gualandi F, Martino G, Marmont A et al. Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. Mult Scler 2005; 11: 367\u2013371.","journal-title":"Mult Scler"},{"key":"BFbmt2011185_CR126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1352458510364538","volume":"16","author":"E Krasulov\u00e1","year":"2010","unstructured":"Krasulov\u00e1 E, Trneny M, Koz\u00e1k T, Vackov\u00e1 B, Pohlreich D, Kemlink D et al. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Mult Scler 2010; 16: 685\u2013693.","journal-title":"Mult Scler"},{"key":"BFbmt2011185_CR127","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bmt.2009.127","volume":"45","author":"N Hamerschlak","year":"2010","unstructured":"Hamerschlak N, Rodrigues M, Moraes DA, Oliveira MC, Stracieri AB, Pieroni F et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM\/horse ATG and CY\/rabbit ATG. Bone Marrow Transplant 2010; 45: 239\u2013248.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00277-010-1071-5","volume":"90","author":"J Xu","year":"2011","unstructured":"Xu J, Ji B-X, Su L, Dong HQ, Sun WL, Wan SG et al. Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Ann Hematol 2011; 90: 343\u2013348.","journal-title":"Ann Hematol"},{"key":"BFbmt2011185_CR129","first-page":"1:S8","volume":"45","author":"M Freedman","year":"2010","unstructured":"Freedman M, Amato M, Atkins H, Carreras E, Fassas A, Griffith LM et al. Panel session report: multiples sclerosis. Bone Marrow Transplant 2010; 45: 1:S8\u20131:10.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR130","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.0b013e318211c537","volume":"76","author":"A Fassas","year":"2011","unstructured":"Fassas A, Kimiskidis VK, Sakellari I, Kapinas K, Anagnostopoulos A, Tsimourtou V et al. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology 2011; 76: 1066\u20131070.","journal-title":"Neurology"},{"key":"BFbmt2011185_CR131","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T . Scleroderma. N Engl J Med 2009; 360: 1989\u20132003.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR132","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139\u2013153.","journal-title":"Medicine (Baltimore)"},{"key":"BFbmt2011185_CR133","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","volume":"26","author":"DJ Abraham","year":"2005","unstructured":"Abraham DJ, Varga J . Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 2005; 26: 587\u2013595.","journal-title":"Trends Immunol"},{"key":"BFbmt2011185_CR134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","volume":"103","author":"SI Nihtyanova","year":"2010","unstructured":"Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP . Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. Q J Med 2010; 103: 109\u2013115.","journal-title":"Q J Med"},{"key":"BFbmt2011185_CR135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/ard.2009.127621","volume":"70","author":"RT Domsic","year":"2011","unstructured":"Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger Jr TA . Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis 2011; 70: 104\u2013109.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR136","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","volume":"118","author":"JPA Ioannidis","year":"2005","unstructured":"Ioannidis JPA, Vlachoyiannopoulos PG, Haidich A-B, Medsger Jr TA, Lucas M, Michet CJ et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005; 118: 2\u201310.","journal-title":"Am J Med"},{"key":"BFbmt2011185_CR137","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005792-200203000-00005","volume":"81","author":"L Scussel-Lonzetti","year":"2002","unstructured":"Scussel-Lonzetti L, Joyal F, Raynauld J-P, Roussin A, Rich E, Goulet JR et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002; 81: 154\u2013167.","journal-title":"Medicine (Baltimore)"},{"key":"BFbmt2011185_CR138","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655\u20132666.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR139","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","volume":"10","author":"C Nannini","year":"2008","unstructured":"Nannini C, West CP, Erwin PJ, Matteson EL . Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008; 10: R124.","journal-title":"Arthritis Res Ther"},{"key":"BFbmt2011185_CR140","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2141.2002.03895.x","volume":"119","author":"D Farge","year":"2002","unstructured":"Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N et al. Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I\u2013II study. Br J Haematol 2002; 119: 726\u2013739.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR141","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1002\/art.22207","volume":"54","author":"G Martini","year":"2006","unstructured":"Martini G, Foeldvari I, Russo R, Cuttica R, Eberhard A, Ravelli A et al. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Arthritis Rheum 2006; 54: 3971\u20133978.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR142","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/rheumatology\/38.11.1130","volume":"38","author":"N Sutcliffe","year":"1999","unstructured":"Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA . The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999; 38: 1130\u20131137.","journal-title":"Rheumatology (Oxford)"},{"key":"BFbmt2011185_CR143","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore) 2003; 82: 299\u2013308.","journal-title":"Medicine (Baltimore)"},{"key":"BFbmt2011185_CR144","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/0961203309106831","volume":"18","author":"R Cervera","year":"2009","unstructured":"Cervera R, Khamashta MA, Hughes GRV . The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus 2009; 18: 869\u2013874.","journal-title":"Lupus"},{"key":"BFbmt2011185_CR145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/ard.62.5.435","volume":"62","author":"C Fiehn","year":"2003","unstructured":"Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K . Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 2003; 62: 435\u2013439.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR146","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/0003-4819-135-4-200108210-00009","volume":"135","author":"GG Illei","year":"2001","unstructured":"Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 2001; 135: 248\u2013257.","journal-title":"Ann Intern Med"},{"key":"BFbmt2011185_CR147","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","volume":"350","author":"G Contreras","year":"2004","unstructured":"Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971\u2013980.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR148","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"FA Houssiau","year":"2002","unstructured":"Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002; 46: 2121\u20132131.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR149","first-page":"1256","volume":"11","author":"M Gayed","year":"2010","unstructured":"Gayed M, Gordon C . Novel treatments for systemic lupus erythematosus. Curr Opin Invest Drugs 2010; 11: 1256\u20131264.","journal-title":"Curr Opin Invest Drugs"},{"key":"BFbmt2011185_CR150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0961203307077987","volume":"16","author":"J Nossent","year":"2007","unstructured":"Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M et al. Current causes of death in systemic lupus erythematosus in Europe, 2000\u20132004: relation to disease activity and damage accrual. Lupus 2007; 16: 309\u2013317.","journal-title":"Lupus"},{"key":"BFbmt2011185_CR151","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","volume":"119","author":"A Doria","year":"2006","unstructured":"Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119: 700\u2013706.","journal-title":"Am J Med"},{"key":"BFbmt2011185_CR152","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","volume":"69","author":"FA Houssiau","year":"2010","unstructured":"Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis 2010; 69: 61\u201364.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR153","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527\u2013535.","journal-title":"JAMA"},{"key":"BFbmt2011185_CR154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00393-008-0359-5","volume":"68","author":"T Alexander","year":"2009","unstructured":"Alexander T, Biesen R, Jacobi A, Hoyer B, Bruns A, Hiepe F . Systemic lupus erythematosus. Target criteria for treatment. Z Rheumatol 2009; 68: 23\u201329.","journal-title":"Z Rheumatol"},{"key":"BFbmt2011185_CR155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(02)07284-7","volume":"359","author":"F Shanahan","year":"2002","unstructured":"Shanahan F . Crohn's disease. Lancet 2002; 359: 62\u201369.","journal-title":"Lancet"},{"key":"BFbmt2011185_CR156","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/adc.74.5.460","volume":"74","author":"M Cosgrove","year":"1996","unstructured":"Cosgrove M, Al-Atia RF, Jenkins HR . The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996; 74: 460\u2013461.","journal-title":"Arch Dis Child"},{"key":"BFbmt2011185_CR157","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(00)05063-7","volume":"357","author":"J Hampe","year":"2001","unstructured":"Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925\u20131928.","journal-title":"Lancet"},{"key":"BFbmt2011185_CR158","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/j.1572-0241.2005.00224.x","volume":"100","author":"T Jess","year":"2005","unstructured":"Jess T, Riis L, Jespersgaard C, Hougs L, Andersen PS, Orholm MK et al. Disease concordance, zygosity, and NOD2\/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Am J Gastroenterol 2005; 100: 2486\u20132492.","journal-title":"Am J Gastroenterol"},{"key":"BFbmt2011185_CR159","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1182\/blood-2010-09-309252","volume":"116","author":"RA Nash","year":"2010","unstructured":"Nash RA, McDonald GB . Crohn disease: remissions but no cure. Blood 2010; 116: 5790\u20135791.","journal-title":"Blood"},{"key":"BFbmt2011185_CR160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"Anon","year":"2003","unstructured":"Anon . Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574\u2013596.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR161","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168\u2013186.","journal-title":"Blood"},{"key":"BFbmt2011185_CR162","volume-title":"The Autoimmune Disease","author":"N Rose","year":"2006","unstructured":"Rose N, Mackay I . The Autoimmune Disease, 4th edn. Elsevier Academic Press: San Diego, CA, 2006."},{"key":"BFbmt2011185_CR163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2141.2005.05809.x","volume":"132","author":"A Norton","year":"2006","unstructured":"Norton A, Roberts I . Management of Evans syndrome. Br J Haematol 2006; 132: 125\u2013137.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR164","first-page":"1:S14","volume":"45","author":"J Passweg","year":"2010","unstructured":"Passweg J, Storek J, Biletti C, Guanlandi F, Rabusin M . Panel session report: autoimmune cytopenias. Bone Marrow Transplant 2010; 45: 1:S14.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2001-12-0171","volume":"101","author":"RD Huhn","year":"2003","unstructured":"Huhn RD, Fogarty PF, Nakamura R, Read EJ, Leitman SF, Rick ME et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 2003; 101: 71\u201377.","journal-title":"Blood"},{"key":"BFbmt2011185_CR166","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003; 48: 1093\u20131101.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR167","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/art.20944","volume":"52","author":"S Yokota","year":"2005","unstructured":"Yokota S, Miyamae T, Imagawa T, Iwata N, Katakura S, Mori M et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 818\u2013825.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR168","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/art.20859","volume":"52","author":"RJ Verburg","year":"2005","unstructured":"Verburg RJ, Sont JK, van Laar JM . Reduction of joint damage in severe rheumatoid arthritis by high-dose chemotherapy and autologous stem cell transplantation. Arthritis Rheum 2005; 52: 421\u2013424.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR169","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.21219","volume":"52","author":"YKO Teng","year":"2005","unstructured":"Teng YKO, Verburg RJ, Sont JK, van den Hout WB, Breedveld FC, van Laar JM . Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation. Arthritis Rheum 2005; 52: 2272\u20132276.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/08916930802198550","volume":"41","author":"JA Snowden","year":"2008","unstructured":"Snowden JA, Kapoor S, Wilson AG . Stem cell transplantation in rheumatoid arthritis. Autoimmunity 2008; 41: 625\u2013631.","journal-title":"Autoimmunity"},{"key":"BFbmt2011185_CR171","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","volume":"52","author":"KA Keogh","year":"2005","unstructured":"Keogh KA, Wylam ME, Stone JH, Specks U . Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 262\u2013268.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR172","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5414\/CNP64485","volume":"64","author":"I K\u00f6tter","year":"2005","unstructured":"K\u00f6tter I, Daikeler T, Amberger C, Tyndall A, Kanz L . Autologous stem cell transplantation of treatment-resistant systemic vasculitis\u2014a single center experience and review of the literature. Clin Nephrol 2005; 64: 485\u2013489.","journal-title":"Clin Nephrol"},{"key":"BFbmt2011185_CR173","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1532\/IJH97.05148","volume":"83","author":"A Kunitomi","year":"2006","unstructured":"Kunitomi A, Ishikawa T, Tajima K, Konaka Y, Yagita M . Bone marrow transplantation with a reduced-intensity conditioning regimen in a patient with Wegener granulomatosis and therapy-related leukemia. Int J Hematol 2006; 83: 262\u2013265.","journal-title":"Int J Hematol"},{"key":"BFbmt2011185_CR174","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2005.035410","volume":"65","author":"B Maurer","year":"2006","unstructured":"Maurer B, Hensel M, Max R, Fiehn C, Ho AD, Lorenz HM . Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis 2006; 65: 127\u2013129.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR175","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/ard.2007.070227","volume":"67","author":"L Statkute","year":"2008","unstructured":"Statkute L, Oyama Y, Barr WG, Sufit R, Ho S, Verda L et al. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis 2008; 67: 991\u2013997.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR176","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1365-2141.2001.02804-2.x","volume":"113","author":"S Bingham","year":"2001","unstructured":"Bingham S, Griffiths B, McGonagle D, Snowden JA, Morgan G, Emery P . Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up. Br J Haematol 2001; 113: 840\u2013841.","journal-title":"Br J Haematol"},{"key":"BFbmt2011185_CR177","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10067-005-1109-6","volume":"24","author":"K Oryoji","year":"2005","unstructured":"Oryoji K, Himeji D, Nagafuji K, Horiuchi T, Tsukamoto H, Gondo H et al. Successful treatment of rapidly progressive interstitial pneumonia with autologous peripheral blood stem cell transplantation in a patient with dermatomyositis. Clin Rheumatol 2005; 24: 637\u2013640.","journal-title":"Clin Rheumatol"},{"key":"BFbmt2011185_CR178","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2005.037879","volume":"65","author":"H Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K et al. A phase I\u2013II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis 2006; 65: 508\u2013514.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR179","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03009740903096622","volume":"39","author":"U Holzer","year":"2010","unstructured":"Holzer U, van Royen-Kerkhof A, van der Torre P, Kuemmerle-Deschner J, Well C, Handgretinger R et al. Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis. Scand J Rheumatol 2010; 39: 88\u201392.","journal-title":"Scand J Rheumatol"},{"key":"BFbmt2011185_CR180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.72.1.127","volume":"72","author":"M Vermeulen","year":"2002","unstructured":"Vermeulen M, Van Oers MH . Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatr 2002; 72: 127\u2013128.","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"BFbmt2011185_CR181","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/08916930802198253","volume":"41","author":"MA Kazmi","year":"2008","unstructured":"Kazmi MA, Mahdi-Rogers M, Sanvito L . Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation? Autoimmunity 2008; 41: 611\u2013615.","journal-title":"Autoimmunity"},{"key":"BFbmt2011185_CR182","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","volume":"14","author":"M Mahdi-Rogers","year":"2009","unstructured":"Mahdi-Rogers M, Kazmi M, Ferner R, Hughes RA, Renaud S, Steck AJ et al. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Peripher Nerv Syst 2009; 14: 118\u2013124.","journal-title":"J Peripher Nerv Syst"},{"key":"BFbmt2011185_CR183","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PYK Van den Bergh","year":"2010","unstructured":"Van den Bergh PYK, Hadden RDM, Bouche P, Cornblath DR, Hahn A, Illa I et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014first revision. Eur J Neurol 2010; 17: 356\u2013363.","journal-title":"Eur J Neurol"},{"key":"BFbmt2011185_CR184","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/NRL.0b013e3181b126e3","volume":"16","author":"F Peng","year":"2010","unstructured":"Peng F, Qiu W, Li J, Hu X, Huang R, Lin D et al. A preliminary result of treatment of neuromyelitis optica with autologous peripheral hematopoietic stem cell transplantation. Neurologist 2010; 16: 375\u2013378.","journal-title":"Neurologist"},{"key":"BFbmt2011185_CR185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneurol.2011.38","volume":"68","author":"M Matiello","year":"2011","unstructured":"Matiello M, Pittock SJ, Porrata L, Weinshenker BG . Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica. Arch Neurol 2011; 68: 933\u2013935.","journal-title":"Arch Neurol"},{"key":"BFbmt2011185_CR186","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","volume":"287","author":"Epidemiology of Diabetes Interventions and Complications Research Group","year":"2002","unstructured":"Epidemiology of Diabetes Interventions and Complications Research Group. The effect of intensive insulin therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 2563\u20132569.","journal-title":"JAMA"},{"issue":"Suppl I","key":"BFbmt2011185_CR187","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.27.2007.S5","volume":"27","author":"American Diabetes Association","year":"2004","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care 2004; 27 (Suppl I): S5\u2013S10.","journal-title":"Diabetes Care"},{"key":"BFbmt2011185_CR188","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","volume":"361","author":"MD Pescovitz","year":"2009","unstructured":"Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009; 361: 2143\u20132152.","journal-title":"N Engl J Med"},{"key":"BFbmt2011185_CR189","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1196\/annals.1447.048","volume":"1150","author":"JC Voltarelli","year":"2008","unstructured":"Voltarelli JC, Couri CEB, Stracieri ABPL, Oliveira MC, Moraes DA, Pieroni F et al. Autologous hematopoietic stem cell transplantation for type 1 diabetes. Ann N Y Acad Sci 2008; 1150: 220\u2013229.","journal-title":"Ann N Y Acad Sci"},{"key":"BFbmt2011185_CR190","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/bmj.39316.442338.AD","volume":"335","author":"AD Hopper","year":"2007","unstructured":"Hopper AD, Hadjivassiliou M, Butt S, Sanders DS . Adult coeliac disease. BMJ 2007; 335: 558\u2013562.","journal-title":"BMJ"},{"key":"BFbmt2011185_CR191","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","volume":"109","author":"A Al-toma","year":"2007","unstructured":"Al-toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 2007; 109: 2243\u20132249.","journal-title":"Blood"},{"key":"BFbmt2011185_CR192","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","volume":"46","author":"GJ Tack","year":"2010","unstructured":"Tack GJ, Wondergem MJ, Al-Toma A, Verbeek WH, Schmittel A, Machado MV et al. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant 2010; 46: 840\u2013846.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR193","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1002\/art.21380","volume":"52","author":"GJ McColl","year":"2005","unstructured":"McColl GJ, Szer J, Wicks IP . Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantation. Arthritis Rheum 2005; 52: 3322.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR194","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703336","volume":"29","author":"MA Zaydan","year":"2002","unstructured":"Zaydan MA, Turner C, Miller AM . Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant. Bone Marrow Transplant 2002; 29: 87\u201389.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR195","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/ard.2004.034793","volume":"64","author":"M van Oosterhout","year":"2005","unstructured":"van Oosterhout M, Verburg RJ, Levarht EWN, Moolenburgh JD, Barge RM, Fibbe WE et al. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities. Ann Rheum Dis 2005; 64: 1783\u20131785.","journal-title":"Ann Rheum Dis"},{"key":"BFbmt2011185_CR196","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1703897","volume":"31","author":"JP Butler","year":"2003","unstructured":"Butler JP, Durrant STS, Frost T . Successful remission of chronic, refractory autoimmune thrombocytopenic purpura following non-myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2003; 31: 621\u2013622.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR197","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.20451","volume":"50","author":"RK Burt","year":"2004","unstructured":"Burt RK, Oyama Y, Verda L, Quigley K, Brush M, Yaung K et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50: 2466\u20132470.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR198","first-page":"2513","volume":"31","author":"O Khorshid","year":"2004","unstructured":"Khorshid O, Hosing C, Bibawi S, Ueno N, Reveille J, Mayes MD et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004; 31: 2513\u20132516.","journal-title":"J Rheumatol"},{"key":"BFbmt2011185_CR199","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/art.21908","volume":"54","author":"RA Nash","year":"2006","unstructured":"Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. Arthritis Rheum 2006; 54: 1982\u20131986.","journal-title":"Arthritis Rheum"},{"key":"BFbmt2011185_CR200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bmt.1705359","volume":"37","author":"Q Lu","year":"2006","unstructured":"Lu Q, Lu L, Niu X, Guo Y, Parino GR, Liu D . Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus. Bone Marrow Transplant 2006; 37: 979\u2013981.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR201","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00393-008-0386-2","volume":"67","author":"I K\u00f6tter","year":"2008","unstructured":"K\u00f6tter I, Schmalzing M, Henes J, Vogel W, Kanz L . Current value of stem-cell transplantation in autoimmune diseases. Z Rheumatol 2008; 67: 716\u2013722.","journal-title":"Z Rheumatol"},{"key":"BFbmt2011185_CR202","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/bmt.2010.126","volume":"46","author":"A Lawitschka","year":"2011","unstructured":"Lawitschka A, Peters C, Seidel MG, Havranek A, Heitger A, Fazekas T et al. Long-term remission in pediatric Wegener granulomatosis following allo-SCT after reduced-intensity conditioning. Bone Marrow Transplant 2011; 46: 462\u2013463.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2011185_CR203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"JD Rizzo","year":"2006","unstructured":"Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138\u2013151.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2011185_CR204","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498\u2013506.","journal-title":"Lancet"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bmt2011185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bmt2011185","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bmt2011185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T19:43:36Z","timestamp":1741808616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2011185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,17]]},"references-count":205,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["BFbmt2011185"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2011.185","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,17]]}}}